Literature DB >> 16928373

Acetylcholine neuroprotection against glutamate-induced excitotoxicity in adult pig retinal ganglion cells is partially mediated through alpha4 nAChRs.

S A Thompson1, O Smith, D M Linn, C L Linn.   

Abstract

In the mammalian retina, excess glutamate release has been shown to be involved in retinal ganglion cell (RGC) death associated with various diseases. Recent studies have determined that activation of alpha7 nicotinic acetylcholine receptors (nAChRs) partially protect isolated RGCs from glutamate-induced excitotoxicity. In this study, we further classify the types of nAChRs involved in neuroprotection against glutamate-induced excitotoxicity using isolated adult pig RGCs. Cells were isolated with a modified two-step immunoselective panning technique designed to isolate RGCs from other retinal neurons. Once isolated, nAChR subunits were identified using a combination of pharmacological and immunocytochemical techniques. In cell culture experiments, a variety of alpha4 nAChR specific agonists were found to have a partial neuroprotective against glutamate-induced excitotoxicity. This neuroprotection was abolished in the presence of the alpha4 nAChR antagonist, dihydro-beta-erythroidine (DHbetaE). Immunocytochemical results localized several nAChR subunits on isolated adult pig RGCs; in particular alpha4, alpha7 and beta2 nAChR subunits. Large RGCs exclusively immunostained with antibodies against alpha7 nAChR subunits whereas alpha4 and beta2 subunits exclusively immunostained only small RGCs. Double label experiments provided evidence that alpha4 and beta2 subunits co-localize on small RGCs. Knowledge of the receptor subtypes responsible for neuroprotection may lead to treatments associated with glutamate-induced excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928373     DOI: 10.1016/j.exer.2006.05.022

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  17 in total

1.  Evidence of BrdU-positive retinal neurons after application of an Alpha7 nicotinic acetylcholine receptor agonist.

Authors:  Mark K Webster; Cynthia A Cooley-Themm; Joseph D Barnett; Harrison B Bach; Jessica M Vainner; Sarah E Webster; Cindy L Linn
Journal:  Neuroscience       Date:  2017-01-29       Impact factor: 3.590

Review 2.  Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance.

Authors:  Merouane Bencherif
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

3.  Calcium preconditioning triggers neuroprotection in retinal ganglion cells.

Authors:  S K Brandt; M E Weatherly; L Ware; D M Linn; C L Linn
Journal:  Neuroscience       Date:  2010-10-31       Impact factor: 3.590

4.  ACh receptors link two signaling pathways to neuroprotection against glutamate-induced excitotoxicity in isolated RGCs.

Authors:  Chinwe O Asomugha; David M Linn; Cindy L Linn
Journal:  J Neurochem       Date:  2009-10-21       Impact factor: 5.372

5.  A nicotinic acetylcholine receptor agonist prevents loss of retinal ganglion cells in a glaucoma model.

Authors:  Kazuhiro Iwamoto; Patrick Birkholz; Austin Schipper; David Mata; David M Linn; Cindy L Linn
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-24       Impact factor: 4.799

Review 6.  What can we learn about stroke from retinal ischemia models?

Authors:  Philippe M D'Onofrio; Paulo D Koeberle
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

7.  Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals.

Authors:  Xiaojuan Sun; Jeffrey D Ritzenthaler; Ying Zheng; Jesse Roman; ShouWei Han
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

8.  Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors.

Authors:  K Iwamoto; D Mata; D M Linn; C L Linn
Journal:  Neuroscience       Date:  2013-02-10       Impact factor: 3.590

9.  Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors.

Authors:  David Mata; David M Linn; Cindy L Linn
Journal:  Neuropharmacology       Date:  2015-07-31       Impact factor: 5.250

10.  Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action.

Authors:  Michael M Swartz; David M Linn; Cindy L Linn
Journal:  Neuropharmacology       Date:  2013-05-29       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.